Cargando…
Small molecule induced reactivation of mutant p53 in cancer cells
The p53 cancer mutant Y220C is an excellent paradigm for rescuing the function of conformationally unstable p53 mutants because it has a unique surface crevice that can be targeted by small-molecule stabilizers. Here, we have identified a compound, PK7088, which is active in vitro: PK7088 bound to t...
Autores principales: | Liu, Xiangrui, Wilcken, Rainer, Joerger, Andreas C., Chuckowree, Irina S., Amin, Jahangir, Spencer, John, Fersht, Alan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695503/ https://www.ncbi.nlm.nih.gov/pubmed/23630318 http://dx.doi.org/10.1093/nar/gkt305 |
Ejemplares similares
-
Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences
por: Brázdová, Marie, et al.
Publicado: (2009) -
Testing mechanisms of DNA sliding by architectural DNA-binding proteins: dynamics of single wild-type and mutant protein molecules in vitro and in vivo
por: Kamagata, Kiyoto, et al.
Publicado: (2021) -
Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023) -
Diverse targets of SMN2-directed splicing-modulating small molecule therapeutics for spinal muscular atrophy
por: Ottesen, Eric W, et al.
Publicado: (2023) -
STAT1:DNA sequence-dependent binding modulation by phosphorylation, protein:protein interactions and small-molecule inhibition
por: Bonham, Andrew J., et al.
Publicado: (2013)